Molecular Basis of Resveratrol-Induced Resensitization of Acquired Drug-Resistant Cancer Cells.
Nutrients
; 14(3)2022 Feb 07.
Article
em En
| MEDLINE
| ID: mdl-35277058
ABSTRACT
Multidrug resistance (MDR) to anticancer drugs remains a serious obstacle to the success of cancer chemotherapy. Resveratrol, a polyphenol, present in natural products exerts anticancer activity and acts as a potential MDR inhibitor in various drug-resistant cancer cells. In the process of resensitization of drug-resistant cancer cells, resveratrol has been shown to interfere with ABC transporters and drug-metabolizing enzymes, increase DNA damage, inhibit cell cycle progression, and induce apoptosis and autophagy, as well as prevent the induction of epithelial to mesenchymal transition (EMT) and cancer stem cells (CSCs). This review summarizes the mechanisms by which resveratrol counteracts MDR in acquired drug-resistant cancer cell lines and provides a critical basis for understanding the regulation of MDR as well as the development of MDR-inhibiting drugs.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transição Epitelial-Mesenquimal
/
Neoplasias
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article